Governance
Information Regarding Our Board of Directors
Annual Election of Directors
Our Board members
stand for election each year. They serve until the next annual meeting of stockholders or until their respective successors are elected and qualify, subject to their prior resignation, retirement, death, disqualification, or removal from office. We
do not have a classified board and our charter bars us, absent the approval of our stockholders, from adopting the Maryland Unsolicited Takeover Act, which, among other things, permits the board of directors of a Maryland corporation to classify
itself without a stockholder vote. We maintain a majority vote standard and director resignation policy for uncontested director elections.
Independent Directors
A majority of our Board and each of our Audit Committee, the Compensation Committee and the Ethics, Nominating and Corporate Governance Committee is comprised of
directors who qualify as independent under the standards of the New York Stock Exchange (the NYSE). Each year, we affirmatively determine that each director deemed independent under NYSE standards has no material relationship with us
(either directly or as a partner, stockholder or officer of an organization that has a relationship with us). The Board of Directors has determined that six of the director nomineesG. Steven Dawson, Caterina A. Mozingo, Elizabeth N. Pitman, D.
Paul Sparks, Jr., Michael G. Stewart and C. Reynolds Thompson, IIIhave no relationship with us that would interfere with their ability to exercise independent judgment as a member of our Board, and that they otherwise qualify as
independent under NYSE standards.
Independent Board Leadership
Two of Medical
Properties Trusts founders serve as members of the Board of Directors. Studies regularly show that founder-led companies outperform their
peers[i]. We are therefore fortunate not to have to rely exclusively on governance mechanisms to ensure that our Board exercises robust, effective, and independent leadership.
We preserve the benefits that founder-led companies enjoy by maintaining our founder, Mr. Aldag, as Chairman and Chief
Executive Officer. That dynamic is of particular importance in a founder-led company like ours, though we regularly review this structure and its alternatives.
We supplement our Boards independence with a Lead Independent Director, currently Mr. Stewart, to whom the Board has given substantial powers and authorities.
Our Lead Independent Director presides at all meetings of the Board at which the Chairman is not present and at all executive sessions of the independent directors. He serves as principal liaison between the Chairman and the independent directors,
advising the Chairman on the quality, quantity and timeliness of the information presented to the Board. He advises the Chairman on the agendas for Board meetings and calls meetings of the independent directors if deemed necessary or appropriate.
The Lead Independent Director also oversees the annual self-evaluation of the Board. The Board can also, at its discretion, supplement the Lead Independent Directors responsibilities.
We believe there are risks in relying exclusively on independent board chairs or lead independent directors for board independence. We therefore valueand
havestrong independent committee chairs on our Board. We also believe that our founder-led culture enables robust and honest interactions from all of our Board members, each of whom brings important and
diverse skill sets to their jobs. Finally, the Board completes an annual board self-evaluation process that is instituted by our Lead Independent Director and presented to the full Board.
[i]
See, Chris Zook, Founder-Led Companies Outperform the RestHeres Why in Harvard Business Review, March 24, 2016.
6 Proxy Statement and Notice of 2020 Annual Meeting